Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

A 12-month clinical trial in 14 adults with SCD evaluated the effects of vitamin D₂ (50,000 IU weekly for 8 weeks, then every other week for 44 weeks) plus calcium carbonate (1,000 mg/day).(Adewoye et al. 2008) Hypocalcaemia was observed in 14% of patients, with serum calcium levels significantly lower in individuals with SCD compared with controls, and 12% of patients had 25(OH)D concentrations below the normal range.

Source: Children and young adults. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Narrative review.

Narrative review

Discusses existing research; systematic-review methods have not been established by this classification.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Macronutrient and micronutrient requirements in sickle cell disease across age groups: a narrative review

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Macronutrient and micronutrient requirements in sickle cell disease across age groups: a narrative review

Narrative review · Journal of Community Genetics · 2026

Original publication title

Macronutrient and micronutrient requirements in sickle cell disease across age groups: a narrative review

Sarbasree Bhattacharjee; Jarina Begum; Ranjitha S Shetty; Syed Irfan Ali; Gaurav Kumar Roy

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Major gaps remain in standardised dietary recommendations and supplementation protocols. Large, high‑quality randomised controlled trials are urgently needed to establish evidence‑based nutritional guidelines for SCD.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Sickle cell disease (SCD) is a hereditary haemoglobinopathy characterised by chronic haemolysis, inflammation, oxidative stress, and increased metabolic demands. Nutritional deficiencies worsen disease severity, growth, immunity, and quality of life, but evidence on age‑specific needs is fragmented. This narrative review synthesises current evidence on macronutrient and micronutrient requirements, deficiencies, and interventions in SCD across age groups.

Source: Background

Abstract: What methods does the paper describe?

A structured literature search was conducted in PubMed, Scopus, and Google Scholar (January 2000-March 2025). Original studies evaluating nutritional status or interventions in confirmed SCD were included.

Source: Methods

Abstract: Results

Individuals with SCD are in a hypermetabolic state with elevated energy and protein requirements. Common micronutrient deficiencies include vitamin D (prevalence 56.2% in children, 75.5% in adults), zinc, vitamin B12, folate, and vitamin C. Zinc deficiency is associated with more vaso‑occlusive crises, infections, delayed growth, and hospitalisations. Omega‑3 fatty acids, L‑arginine, glutamine, zinc, and vitamin D supplementation show potential benefits in reducing pain severity, vaso‑occlusive events, inflammation, and hospital admissions, while improving growth, endothelial function, and quality of life. However, the certainty of the evidence is low to very low due to small sample sizes and heterogeneous methods; adult‑specific data are particularly scarce.

Source: Results

Abstract: Conclusion

Major gaps remain in standardised dietary recommendations and supplementation protocols. Large, high‑quality randomised controlled trials are urgently needed to establish evidence‑based nutritional guidelines for SCD.

Source: Conclusion
Authors’ abstract

Background

Sickle cell disease (SCD) is a hereditary haemoglobinopathy characterised by chronic haemolysis, inflammation, oxidative stress, and increased metabolic demands. Nutritional deficiencies worsen disease severity, growth, immunity, and quality of life, but evidence on age‑specific needs is fragmented. This narrative review synthesises current evidence on macronutrient and micronutrient requirements, deficiencies, and interventions in SCD across age groups.

Methods

A structured literature search was conducted in PubMed, Scopus, and Google Scholar (January 2000-March 2025). Original studies evaluating nutritional status or interventions in confirmed SCD were included.

Results

Individuals with SCD are in a hypermetabolic state with elevated energy and protein requirements. Common micronutrient deficiencies include vitamin D (prevalence 56.2% in children, 75.5% in adults), zinc, vitamin B12, folate, and vitamin C. Zinc deficiency is associated with more vaso‑occlusive crises, infections, delayed growth, and hospitalisations. Omega‑3 fatty acids, L‑arginine, glutamine, zinc, and vitamin D supplementation show potential benefits in reducing pain severity, vaso‑occlusive events, inflammation, and hospital admissions, while improving growth, endothelial function, and quality of life. However, the certainty of the evidence is low to very low due to small sample sizes and heterogeneous methods; adult‑specific data are particularly scarce.

Conclusion

Major gaps remain in standardised dietary recommendations and supplementation protocols. Large, high‑quality randomised controlled trials are urgently needed to establish evidence‑based nutritional guidelines for SCD.

Publication and source details

Original title: Macronutrient and micronutrient requirements in sickle cell disease across age groups: a narrative review

Sarbasree Bhattacharjee; Jarina Begum; Ranjitha S Shetty; Syed Irfan Ali; Gaurav Kumar Roy

Journal of Community Genetics · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:22:38.558767+00:00

DOI: 10.1007/s12687-026-00959-8 · PMC13680318